Latest News
Upstream Bio, Inc.
- Upstream Bio (UPB) Slips 1.42% to $2.78 as Micro-Cap Biotech Tests Lower Support - Order Block
- Upstream Bio (UPB) Falls 18.10% to $2.76 as Shares Test Key Support - Wave Truncation
- Which of Upstream Bio (NASDAQ:UPB), Biofrontera (NASDAQ:BFRI), Aldeyra Therapeutics (NASDAQ:ALDX), KALA BIO (NASDAQ:KALA) or Inovio Pharmaceuticals (NASDAQ:INO) Is the Best Biotech or Pharma Gainer in Pre-Market?
- Upstream Bio (UPB) Slides 2.63% to $3.33 as Shares Drift Toward Lower Support - PCR Spike
- Upstream Bio (UPB) Shares Edge Higher: Stock Gains 3.30% to $4.70 - Iceberg Order
- Upstream Bio (UPB) Shares Edge Higher: Stock Gains 3.30% to $4.70 - Dividend Growth Stocks
Headlines from the last 30 days, linking to the original publishers. See all market news →